Transgenic tissue‐type plasminogen activator expression improves host defense during Klebsiella pneumonia

Rosemarijn Renckens; Joris J. T. H. Roelofs; Michiel E. Stegenga; Sandrine Florquin; Marcel Levi; Peter Carmeliet; Cornelis van ‘t Veer; Tom van der Poll

doi:10.1111/j.1538-7836.2008.02892.x

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2006

Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia

Rosemarijn Renckens, Joris J. T. H. Roelofs, Peter I. Bonta, Sandrine Florquin, Carlie J.M. de Vries, Marcel Levi, Peter Carmeliet, Cornelis van’t Veer, Tom van der Poll

Article1997

Adenovirus-Mediated Transfer of Tissue-Type Plasminogen Activator Augments Thrombolysis in Tissue-Type Plasminogen Activator–Deficient and Plasminogen Activator Inhibitor-1–Overexpressing Mice

Peter Carmeliet, Jean-Marie Stassen, Ilse Van Vlaenderen, Robert S. Meidell, D Collen, Robert D. Gerard

Article1997

Adenovirus-Mediated Transfer of Tissue-Type Plasminogen Activator Augments Thrombolysis in Tissue-Type Plasminogen Activator–Deficient and Plasminogen Activator Inhibitor-1–Overexpressing Mice

Peter Carmeliet, Jean–Marie Stassen, Ilse Van Vlaenderen, Robert S. Meidell, D Collen, Robert D. Gerard

Article2001

Tissue-Type Plasminogen Activator Deficiency Exacerbates Arthritis

Yuan Yang, Peter Carmeliet, John A. Hamilton

Article1993

Biological effects of inactivation of the genes for tissue-type plasminogen activator, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in mice

Peter Carmeliet, Luc Schoonjans, L Kieckens, Jean Marie Stassen, Roderick T. Bronson, D Collen, R. Mulligant